Merck Adds 10 Studies To ClinicalTrials.gov, Bringing Total To 13
This article was originally published in The Pink Sheet Daily
Executive Summary
The 10 new Merck entries include three Phase III studies in type 2 diabetes. The company's listings are still relatively few when compared to its peers.